Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Seleno Methionine is a well-absorbed organic form of selenium, an essential trace element. Its use in supporting or treating Hashimoto's Disease (autoimmune thyroiditis) is primarily justified by scientific research, though the evidence is moderate and somewhat mixed.

Several randomized controlled trials and meta-analyses have explored the effects of selenium supplementation (often as Seleno Methionine) in patients with Hashimoto's Disease. Some studies demonstrate that selenium supplementation can reduce serum levels of thyroid peroxidase antibodies (TPOAb), which are markers of thyroid autoimmunity. For example, a 2016 meta-analysis (Winther et al., 2016) concluded that selenium supplementation may reduce TPOAb levels and potentially improve the inflammatory status of the thyroid. However, this reduction in antibody levels does not always translate into meaningful clinical improvements, such as better thyroid hormone levels or symptom relief.

Guidelines from major endocrine societies, including the American Thyroid Association, note that while selenium may lower antibody titers, evidence supporting an impact on thyroid function or disease progression is insufficient. Selenium supplementation is not universally recommended for all patients with Hashimoto’s, but may be considered in individuals with documented selenium deficiency.

In summary, Seleno Methionine has scientific support for reducing thyroid antibody levels in Hashimoto's Disease, but the clinical relevance of this effect remains uncertain, and routine supplementation is not broadly endorsed.

More about Seleno Methionine
More about Hashimoto's Disease

Other ingredients used for Hashimoto's Disease

Other health conditions supported by Seleno Methionine

Products containing Seleno Methionine